Navigation Links
Cadence Pharmaceuticals Recognized As A Top Workplace In San Diego Based On Employee Feedback
Date:11/8/2013

SAN DIEGO, Nov. 8, 2013 /PRNewswire/ -- Cadence Pharmaceuticals, Inc. (NASDAQ: CADX), a biopharmaceutical company focused on acquiring, in-licensing, developing and commercializing proprietary products principally for use in the hospital setting, announced today it has been recognized as one of U-T San Diego's Top Workplaces. The Top Workplaces are determined exclusively based on employee feedback provided through an anonymous survey.

"We are extremely honored that our employees' feedback has resulted in this recognition," said Ted Schroeder, President, CEO, and co-founder of Cadence Pharmaceuticals. "Building and sustaining a great working environment and a strong culture has been a top priority since we founded the company in 2004. The leadership team is focused on driving competitive advantage by consistently fostering a strong set of core values and maintaining our dynamic company culture."

The survey, which was conducted by leading research firm on organizational health and employee engagement, WorkplaceDynamics, LLP, included questions around company direction, execution, connection to the company, management, pay and benefits, and employee engagement. Cadence Pharmaceuticals had an exceptional 92 percent employee response rate on the survey.

"The key to Cadence Pharmaceuticals' employee satisfaction is a culture that encourages employee feedback," said Diane Sheehan, Vice President of Human Resources at Cadence Pharmaceuticals. "Each employee is important to our success, so it is imperative that we gather, consider and take action on their input. We believe that this approach will help as we strive to achieve our corporate objectives and provide value to the hospital community and our business partners."

The following anonymous testimonials were excerpted from the survey:

  • "I truly believe in the product I promote and believe I work with the best people in the industry. Management is transparent and supportive all the way up the chain of command. I have never been more satisfied with work."
  • "I am empowered to make decisions and contribute. Our CEO is accessible and easy to approach. [Cadence Pharmaceuticals has a] strong unique culture in which we can all contribute and be a part of the company's success."

In addition, Cadence Pharmaceuticals was recognized as a recipient of a 2013 Workplace Excellence Award presented by the San Diego Society for Human Resource Management's (SD SHRM). This award, which is based on the assessment of an expert judging panel assembled by SD SHRM, recognizes Cadence Pharmaceuticals' proactive efforts to involve its employees in the ongoing strengthening of the company and its culture. This is the second time Cadence Pharmaceuticals has won a SD SHRM Workplace Excellence Award, with the first award in 2010.

Both awards were presented at a ceremony sponsored by U-T San Diego, held at the Hilton La Jolla Torrey Pines on November 7, 2013.

About Cadence Pharmaceuticals, Inc.

Cadence Pharmaceuticals is a biopharmaceutical company focused on acquiring, in-licensing, developing and commercializing proprietary products principally for use in the hospital setting. The current version of Cadence Pharmaceuticals' corporate overview may be viewed on the Investors page of www.cadencepharm.com under "Events & Presentations" by selecting "Corporate Overview."

Cadence® is a trademark of Cadence Pharmaceuticals, Inc.

Investor Contact:
William R. LaRue   
SVP & Chief Financial Officer    
Cadence Pharmaceuticals, Inc.       
Phone: 858-436-1400                                                                                     

Media Contact:
Cuyler Mayer     
Edelman
Phone: 323-202-1073


'/>"/>
SOURCE Cadence Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Cadence Pharmaceuticals Reports Third Quarter 2013 Financial Results
2. Cadence Pharmaceuticals To Host Conference Call And Webcast To Discuss Third Quarter 2013 Financial Results On November 5, 2013
3. Cadence Pharmaceuticals CEO Ted Schroeder To Present At The Stifel Nicolaus Healthcare Conference 2013 On September 11, 2013
4. Cadence Pharmaceuticals Comments on USPTOs Non-Final, Initial Office Action on Reexamination of Patent
5. Cadence Pharmaceuticals Appoints Laureen DeBuono to its Board of Directors
6. Cadence Pharmaceuticals To Present At The 2013 Wedbush PacGrow Life Sciences Management Access Conference On August 13, 2013
7. Cadence Pharmaceuticals Reports Second Quarter 2013 Financial Results
8. Cadence Pharmaceuticals To Host Conference Call And Webcast To Discuss Second Quarter 2013 Financial Results On July 31, 2013
9. Cadence Pharmaceuticals To Present At Three Investment Conferences During The Month Of May 2013
10. Cadence Pharmaceuticals To Host Conference Call And Webcast To Discuss First Quarter 2013 Financial Results On May 2, 2013
11. Cadence Pharmaceuticals Appoints Stephen L. Newman, M.D., to its Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/19/2017)... 19, 2017  Mako Medical Laboratories partnered with Secretary ... Family Assistance Fund (MFA) to bring 140 soldiers back ... with their families one last time before being deployed. ... travel and logistics needed for these soldiers. "Mako Medical ... their families. We just wish we could bring them ...
(Date:7/13/2017)... , July 13, 2017  Centurion Medical Products, a leader ... DisImpactor ® fecal impaction removal device for hospice patient care. ... Centurion ... Patient pain management and emotional ... Hospice can help alleviate patient pain while preventing unneeded emergency department ...
(Date:7/11/2017)... Research Corp., also known as ,The Epigenetics Company, announced today the release ... manner using the myDNAge ™ test. Based on Horvath,s Clock, so ... and biostatistics at the David Geffen School of Medicine at UCLA ... DNAge ™ technology is used to analyze DNA methylation patterns of ... ...
Breaking Medicine Technology:
(Date:7/26/2017)... ... July 26, 2017 , ... Isodiol International Inc. (CSE: ... specializing in the development of pharmaceutical and consumer products, announces the operational numbers ... 30, 2017. Iso International LLC recorded unaudited fiscal Q1 profits of $897,596 based ...
(Date:7/26/2017)... Springs, FL (PRWEB) , ... July 26, 2017 ... ... the nation’s leading innovative specialty pharmacies, has released an updated version of the ... the latest guidelines for treating chronic hepatitis C virus (HCV) infection. All of ...
(Date:7/25/2017)... ... July 25, 2017 , ... Summers in Palm Springs sizzle, but there are ... homemade gourmet ice cream, sparkling pools, and mile-high fun. , At Arrive's Ice Cream ... and other must-have knick knacks. Ice cream and sorbet flavors rotate, but the classics ...
(Date:7/25/2017)... ... July 25, 2017 , ... SureVest Insurance Group, a ... communities across North Carolina, is launching a charity event in conjunction with the ... the ongoing fight against bladder cancer. , The Bladder Cancer Advocacy Network (BCAN) ...
(Date:7/25/2017)... Irving, Texas (PRWEB) , ... July 25, 2017 ... ... and fastest growing ATM provider in the United States, today announced its partnership ... to financial institutions. , The foundation of the solution lies within Hyosung’s ...
Breaking Medicine News(10 mins):